Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Researchers Develop Program to Find Cancer-Related Genes Using Artificial Intelligence
Error: Contact form not found.
by JNS.org
The intensive-care department at Hadassah Ein Karem Hospital in Jerusalem on Sept. 3, 2017. It now has state-of-the-art upgrades. Photo: Hadas Parush/Flash90.
JNS.org – Researchers at the Hadassah-Ein Kerem Hospital in Jerusalem have created a first-of-its-kind artificial intelligence program to recognize cancer-causing mutations.
“Today, we can already say that carriers of a TP53 gene mutation have an increased risk of developing cancer at an early age,” Dr. Shai Rosenberg told i24News.
“Cells in the human body where certain genetic changes have occurred are very likely to become cancer cells. Each of us carries a gene called the TP53 gene, whose function is to protect the normal cells of the body by correcting genetic changes. When too many changes occur, the gene causes a planned ‘suicide’ of the cell, thus preventing the cell from becoming cancerous,” Rosenberg explained.
The first breakthrough was published in the prominent journal “Briefings in Bioinformatics.”
The article stated that the Israeli researchers were able “to create an unprecedented, thoroughly validated and clinically oriented classification model.”
